Literature DB >> 2418697

Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.

M Uribe, C M Fenoglio-Preiser, M Grimes, C Feind.   

Abstract

Twenty medullary carcinomas of the thyroid gland were examined for the presence of immunoreactive calcitonin, thyroglobulin, glucagon, keratin, gastrin/CCK, carcinoembryonic antibody (CEA), insulin, serotonin, adreno-corticotropic hormone (ACTH), prostatic acid phosphatase, and somatostatin using the immunoperoxidase peroxidase-antiperoxidase technique. In addition, they were stained with mucicarmine, alcian blue/periodic acid-Schiff (PAS), Grimelius, Congo red, crystal violet, and Fontana-Masson stains. Calcitonin-immunoreactive cells were absent in one tumor and present in 19 tumors (95%). Thyroglobulin was present in seven tumors (35%). Twenty tumors contained CEA-immunoreactive cells (100%). Fourteen cases were immunoreactive to serotonin (70%) and 12 were positive for somatostatin (60%). Glucagon- and gastrin/CCK-immunoreactive cells were found in two cases each (10%). Four tumors (20%) contained ACTH-immunoreactive cells and three cases (15%) were positive for prostatic acid phosphatase. Five cases (25%) contained keratin-immunoreactive cells. One case was immunoreactive to insulin (5%). Grimelius-positive cells were present in 19 of the cases (95%). Mucin-containing cells were present in 65% of the cases. The validity of the immunocytochemical localizations was tested by specific absorption of each antibody with the corresponding antigen. The demonstration of immunoreactivity for multiple antigens in each of the 20 cases suggests that the origin of medullary thyroid carcinomas is from a neuroendocrine cell potentially capable of producing numerous hormone substances. In addition, as the neoplastic cells in 35% of the tumors contained hormonal substances as well as thyroglobulin, it is suggested that papillary or follicular tumors mixed with a neuroendocrine component exist more commonly than previously suspected. Finally, psammoma bodies might be present in pure medullary carcinoma of the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2418697     DOI: 10.1097/00000478-198508000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

1.  RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.

Authors:  F Orlandi; E Chiefari; P Caraci; A Mussa; I Gonzatto; P De Giuli; D Giuffrida; A Angeli; S Filetti
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

2.  Chronic diarrhoea--all in the bowel?

Authors:  S Gupta; C J Tibbs; M J G Farthing; R C G Pollok
Journal:  J R Soc Med       Date:  2007-08       Impact factor: 5.344

3.  Medullary thyroid carcinoma: a 25-year perspective.

Authors:  Xavier Matias-Guiu; Ronald De Lellis
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

4.  Monoclonal antibodies against calcitonin. Characterization and application in light and electron microscopy immunocytochemistry.

Authors:  L Scopsi; J Arias; G Houen; G Racchetti; G L Fossati; Y M Galante
Journal:  Histochemistry       Date:  1988

Review 5.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

6.  Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.

Authors:  S Schröder; W Schwarz; W Rehpenning; H Dralle; V Bay; W Böcker
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

7.  Coexistence of papillary and medullary carcinoma of the thyroid gland-mixed or collision tumour? Clinicopathological analysis of three cases.

Authors:  S F Lax; A Beham; D Kronberger-Schönecker; W Langsteger; H Denk
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  "Mucin secreting" and "mucinous" primary thyroid carcinomas: pitfalls in mucin histochemistry applied to thyroid tumours.

Authors:  C Rigaud; W V Bogomoletz
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

9.  An unusual presentation of medullary thyroid carcinoma.

Authors:  Sudip Kr Das; Himanshu Varshney; M L Saha; Shubhrakanti Sen; Amit Bikram Maity; Ranjan Paul
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-02-21

10.  Blood group antigen expression in malignant tumors of the thyroid: a parallel between medullary and nonmedullary carcinomas.

Authors:  A Larena; M Vierbuchen; R Fischer
Journal:  Langenbecks Arch Chir       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.